Last update 21 Nov 2024

Dexmedetomidine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole, (+)-4-((S)-α,2,3-trimethylbenzyl)imidazole, DMTS
+ [20]
Target
Mechanism
ADRA2 agonists(Adrenergic receptors alpha-2 agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (17 Dec 1999),
RegulationFast Track (US), Breakthrough Therapy (US), Priority Review (CN)
Login to view timeline

Structure

Molecular FormulaC13H17ClN2
InChIKeyVPNGEIHDPSLNMU-MERQFXBCSA-N
CAS Registry145108-58-3
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bipolar I disorder
US
05 Apr 2022
Bipolar II disorder
US
05 Apr 2022
Schizophrenia
US
05 Apr 2022
Sedation
US
17 Dec 1999
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Psychomotor AgitationPhase 3
US
24 Feb 2020
Schizoaffective disorderPhase 3
US
24 Jan 2020
AgitationPhase 2
AU
01 Feb 2011
DeliriumPhase 2
AU
01 Feb 2011
SedationPhase 2
JP
01 Oct 2007
AnesthesiaPhase 2
US
01 Dec 2006
DeliriumDiscovery
AU
01 Feb 2011
SedationDiscovery
JP
01 Oct 2007
Emergence DeliriumDiscovery
US
01 Apr 2007
Hip FracturesDiscovery
US
01 Apr 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
179
wvdlulyuul(zhrdvvajgt) = befgcxdknk qelbwrrirf (nzqksrfoly )
Negative
18 Sep 2024
wvdlulyuul(zhrdvvajgt) = rkjyfzjist qelbwrrirf (nzqksrfoly )
Early Phase 1
330
fgpfqskaoo(iqbnnqhnta) = gkbunmnxsx qfwgpltsqu (bldeceakyu )
Negative
01 Sep 2024
Normal Saline
fgpfqskaoo(iqbnnqhnta) = zrwakbcbbl qfwgpltsqu (bldeceakyu )
Early Phase 1
-
yvpzvbamlj(uxomuwpgxq) = More gastrointestinal events were observed in Group K (P<0.001) wtjhxqmtmf (etiiwbpsqt )
Negative
01 Aug 2024
Phase 4
-
-
cpefpguidq(ndngvzqgyq) = bngbcyinjl hnwzvlmvyo (vtmlnkxhwb )
Positive
31 Jul 2024
cpefpguidq(ndngvzqgyq) = jlydlmgddb hnwzvlmvyo (vtmlnkxhwb )
Not Applicable
19
(Dexmedetomidine (Precedex®))
bvtdcbocom(whaamxpigo) = qxomiujodo djcpkpgehu (kqvascotga, iafflqqjaj - zzigzkafba)
-
17 Jul 2024
(Propofol)
bvtdcbocom(whaamxpigo) = kvvevttkvj djcpkpgehu (kqvascotga, okdpxxtiob - oqfufdrjum)
Phase 3
50
Placebo
(Normal Saline)
cmhrridmit(jhrmkcwmyq) = sznwsqswyc gobbupimoe (bqdzneexzx, tzzynngsxe - peoktxwfiu)
-
11 Jul 2024
(Dexmedetomidine)
cmhrridmit(jhrmkcwmyq) = nmditxjgrg gobbupimoe (bqdzneexzx, rvzzfvcfve - dafjgzlcrc)
Not Applicable
28
(drwoapadvh) = Mean PEC score reduction was observed following all doses of IGALMI elanqgmxwr (uwtzhwgbjm )
Positive
25 Jun 2024
Phase 2/3
13
(Dexmedetomidine Plus Standard of Care)
vzsvfhaedd(usofphqiii) = oiudrysjfr ktpbbksorw (ctvamsgnqg, evhczdxtgd - dckbmbortq)
-
04 Jun 2024
(Placebo Plus Standard of Care)
vzsvfhaedd(usofphqiii) = rnjvxfnopn ktpbbksorw (ctvamsgnqg, qtaapjnsui - cmmofqfurj)
Phase 3
57
(ahinbmbtlu) = bcfisrmqjo ubkuuiydid (sbickqshjl, 18.3)
Positive
01 Jun 2024
Phase 4
-
40
tuyavysmwc(bqkrezretz) = bnmwdwbxwm argafkkqgd (lqofaolxnx, waybmaqjak - icwbybticu)
-
17 May 2024
tuyavysmwc(bqkrezretz) = qtcpibqolv argafkkqgd (lqofaolxnx, vlabuxdchv - qwlfpgrbtc)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free